F Grossi

Summary

Affiliation: University of Udine
Country: Italy

Publications

  1. ncbi request reprint [Possibilities of thermal medicine in gastrointestinal functional disorders]
    M Grassi
    Dipartimento di Terapia Medica, Universita di Roma La Sapienza, Policlinico Umberto Io, Divisione di Idrologia Medica, Viale de Policlinico, 155 00161 Roma, Italia
    Clin Ter 153:195-206. 2002
  2. ncbi request reprint Geography of clinical cancer research publications from 1995 to 1999
    F Grossi
    Division of Medical Oncology, University of Udine, Pz le S M Misericordia, 33100 Udine, Italy
    Eur J Cancer 39:106-11. 2003
  3. ncbi request reprint Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers
    A Sobrero
    University of Udine, Department of Medical Oncology, Italy
    Ann Oncol 11:1413-20. 2000
  4. ncbi request reprint Fatigue: a main component of anemia symptomatology
    A Sobrero
    Department of Medical Oncology, University of Udine, Italy
    Semin Oncol 28:15-8. 2001
  5. ncbi request reprint Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: results of an Experts Panel Meeting
    C Gridelli
    Division of Medical Oncology, SG Moscati Hospital, Contrada Amoretta, 83100 Avellino, Italy
    Crit Rev Oncol Hematol 66:155-62. 2008
  6. ncbi request reprint Phase II study of neoadjuvant chemotherapy in patients with surgically-proven, unresectable stage III non-small cell lung cancer
    F Grossi
    Department of Medical Oncology, University of Udine, Udine, Italy
    Anticancer Res 22:3519-24. 2002
  7. pmc Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil
    A Guglielmi
    Medical Oncology, Ospedale San Martino, Genova, Italy
    Br J Cancer 91:1428-33. 2004
  8. ncbi request reprint Adjuvant chemotherapy for non-small cell lung cancer: ready for clinical practice?
    M Tiseo
    Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    Eur J Cancer 42:8-16. 2006
  9. ncbi request reprint Maintenance chemotherapy in non-small cell lung cancer
    M Rinaldi
    Istituto Regina Elena per lo Studio e la Cura dei Tumori, Roma, Italy
    Ann Oncol 17:ii67-70. 2006
  10. pmc 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer
    A Sobrero
    GISCAD IOR
    Br J Cancer 84:1023-8. 2001

Collaborators

Detail Information

Publications11

  1. ncbi request reprint [Possibilities of thermal medicine in gastrointestinal functional disorders]
    M Grassi
    Dipartimento di Terapia Medica, Universita di Roma La Sapienza, Policlinico Umberto Io, Divisione di Idrologia Medica, Viale de Policlinico, 155 00161 Roma, Italia
    Clin Ter 153:195-206. 2002
    ....
  2. ncbi request reprint Geography of clinical cancer research publications from 1995 to 1999
    F Grossi
    Division of Medical Oncology, University of Udine, Pz le S M Misericordia, 33100 Udine, Italy
    Eur J Cancer 39:106-11. 2003
    ..These results provide information on the geography of clinical cancer research worldwide, which may reflect the human and economic resources involved in this field...
  3. ncbi request reprint Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers
    A Sobrero
    University of Udine, Department of Medical Oncology, Italy
    Ann Oncol 11:1413-20. 2000
    ..We have compared an alternating regimen of bolus and continuous infusion 5-FU, selectively modulated for the schedule of administration, with modulated bolus 5-FU in advanced colorectal cancer patients...
  4. ncbi request reprint Fatigue: a main component of anemia symptomatology
    A Sobrero
    Department of Medical Oncology, University of Udine, Italy
    Semin Oncol 28:15-8. 2001
    ..Accordingly, the search for new simplified methods of assessment of fatigue and other anemia-related symptoms and their treatment outcomes should be strongly encouraged...
  5. ncbi request reprint Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: results of an Experts Panel Meeting
    C Gridelli
    Division of Medical Oncology, SG Moscati Hospital, Contrada Amoretta, 83100 Avellino, Italy
    Crit Rev Oncol Hematol 66:155-62. 2008
    ....
  6. ncbi request reprint Phase II study of neoadjuvant chemotherapy in patients with surgically-proven, unresectable stage III non-small cell lung cancer
    F Grossi
    Department of Medical Oncology, University of Udine, Udine, Italy
    Anticancer Res 22:3519-24. 2002
    ..In addition, we studied the value of preoperatory magnetic resonance imaging (MRI), in evaluating the probability of achieving a radical resection after neoadjuvant chemotherapy...
  7. pmc Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil
    A Guglielmi
    Medical Oncology, Ospedale San Martino, Genova, Italy
    Br J Cancer 91:1428-33. 2004
    ..Pros and cons of the different fluoropyrimidines-l-OHP combinations are discussed...
  8. ncbi request reprint Adjuvant chemotherapy for non-small cell lung cancer: ready for clinical practice?
    M Tiseo
    Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    Eur J Cancer 42:8-16. 2006
    ..Practical issues and clinical aspects which may help clinicians in the decision making process about prescription of adjuvant treatment are also discussed...
  9. ncbi request reprint Maintenance chemotherapy in non-small cell lung cancer
    M Rinaldi
    Istituto Regina Elena per lo Studio e la Cura dei Tumori, Roma, Italy
    Ann Oncol 17:ii67-70. 2006
  10. pmc 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer
    A Sobrero
    GISCAD IOR
    Br J Cancer 84:1023-8. 2001
    ....
  11. pmc Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials
    G L Ceresoli
    Department of Oncology, Istituto Clinico Humanitas IRCCS, Rozzano, Milano, Italy
    Br J Cancer 99:51-6. 2008
    ..9 months, P=0.12). Apart from slightly worse haematological toxicity, there was no significant difference in outcome or toxicity between age groups. The PC regimen is effective and well tolerated in selected elderly patients with MPM...